Institutional & Family Asset Management’s Acceleron Pharma XLRN Stock Holding History

Institutional & Family Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-16	Closed	-$2K	–	1013
2020 Q4	$2K	Sell	16 -1	-6%	-$117	﹤0.01%	809
2020 Q3	$2K	Hold	17	–	–	﹤0.01%	753
2020 Q2	$2K	Sell	17 -5	-23%	-$482	﹤0.01%	738
2020 Q1	$2K	Hold	22	–	–	﹤0.01%	691
2019 Q4	$1K	Hold	22	–	–	﹤0.01%	842
2019 Q3	$1K	Sell	22 -1	-4%	-$43	﹤0.01%	820
2019 Q2	$1K	Hold	23	–	–	﹤0.01%	830
2019 Q1	$1K	Hold	23	–	–	﹤0.01%	825
2018 Q4	$1K	Hold	23	–	–	﹤0.01%	808
2018 Q3	$1K	Hold	23	–	–	﹤0.01%	832
2018 Q2	$1K	Hold	23	–	–	﹤0.01%	829
2018 Q1	$1K	Buy	+23	New	+$978	﹤0.01%	829

Other funds holding XLRN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Institutional & Family Asset Management's XLRN Position: Q1 2021 in Review

Institutional & Family Asset Management sold out of Acceleron Pharma (XLRN) in Q1 2021, closing a stake of 16 shares — an estimated $2K sold.

Institutional & Family Asset Management first reported a position in XLRN in Q1 2018 and held it in 12 quarters. The position peaked at $2K in Q4 2020. 256 funds tracked by Wall St. Rank hold XLRN as of Q1 2021.

Institutional & Family Asset Management reported no remaining Acceleron Pharma position as of Q1 2021 after selling out during the quarter.
Institutional & Family Asset Management sold 16 Acceleron Pharma shares in Q1 2021, an estimated $2K.
Institutional & Family Asset Management first reported a position in Acceleron Pharma in Q1 2018 and held it in 12 quarters.
Institutional & Family Asset Management's Acceleron Pharma position peaked at $2K in Q4 2020.
256 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2021.

Based on Institutional & Family Asset Management's 13F filing for Q1 2021, filed 6 May 2021.